Editorial: Oxytocin protocols during cesarean delivery: Time to acknowledge the risk/benefit ratio?

International Journal of Obstetric Anesthesia

Volumn 19, Issue 3, 2010, Pages 243-245

  Tsen, Lawrence C ^a   Balki, Mrinalini ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN; OXYTOCIC AGENT;

CESAREAN SECTION; CLINICAL PRACTICE; DRUG SAFETY; EDITORIAL; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ORGANIZATION; HEART ARRHYTHMIA; HUMAN; HYPERBILIRUBINEMIA; HYPONATREMIA; HYPOTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; MEDICAL ERROR; OVARY HYPERSTIMULATION; OXYGEN SATURATION; PATIENT CARE; PATIENT SAFETY; POSTPARTUM HEMORRHAGE; RETINA HEMORRHAGE; RISK ASSESSMENT; SEIZURE; SIDE EFFECT; UTERUS CONTRACTION; ADULT; ALGORITHM; FEMALE; PREGNANCY;

ADULT; ALGORITHMS; CESAREAN SECTION; FEMALE; HUMANS; OXYTOCICS; OXYTOCIN; PREGNANCY; RISK ASSESSMENT;

EID: 77954219469     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijoa.2010.05.001     Document Type: Editorial

References (30)

1. R.K. Freeman, and M. Nageotte A protocol for use of oxytocin Am J Obstet Gynecol 197 2007 445 446
2. R.A. Dyer, D. van Dyk, and A. Dresner The use of uterotonic drugs during caesarean section Int J Obstet Anesth 19 2010 313 319
3. M. Johnstone The cardiovascular effects of oxytocic drugs Br J Anaesth 44 1972 826 834
4. S.W. D'Souza, B. Lieberman, J. Cadman, and B. Richards Oxytocin induction of labour: hyponatraemia and neonatal jaundice Eur J Obstet Gynecol Reprod Biol 22 1986 309 317
5. N. Johnson, E. van Oudgaarden, I. Montague, and H. McNamara The effect of oxytocin-induced hyperstimulation on fetal oxygen BJOG 101 1994 805 807
6. K.R. Simpson, and D.C. James Effects of oxytocin-induced uterine hyperstimulation during labor on fetal oxygen status and fetal heart rate patterns Am J Obstet Gynecol 199 2008 34.e1 34.e5
7. J.M. Beazley, and B. Alderman Neonatal hyperbilirubinaemia following the use of oxytocin in labour BJOG 82 1975 265 271
8. A. Schoenfeld, G. Buckman, I. Nissenkorn, S. Cohen, I. Ben-Sira, and J. Ovadia Retinal hemorrhages in the newborn following labor induced by oxytocin or dinoprostone Arch Ophthalmol 103 1985 932 934
9. Why Mothers Die. The Confidential Enquiries into Maternal Deaths in the United Kingdom 1997-1999. London: RCOG Press; 2001.
10. J.S. Thomas, S.H. Koh, and G.M. Cooper Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section Br J Anaesth 98 2007 116 119
11. M.C. Svanstrom, B. Biber, M. Hanes, G. Johansson, U. Naslund, and E.M. Balfors Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section Br J Anaesth 100 2008 683 689
12. A.J. Butwick, L. Coleman, S.E. Cohen, E.T. Riley, and B. Carvalho Minimum effective bolus dose of oxytocin during elective Caesarean delivery Br J Anaesth 104 2010 338 343
13. A.J. Pinder, M. Dresner, C. Calow, G.D. Shorten, J. O'Riordan, and R. Johnson Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia Int J Obstet Anesth 11 2002 156 159
14. S.L. Clark, M.A. Belfort, G.A. Dildy, and J.A. Meyers Reducing obstetric litigation through alterations in practice patterns - experience with 189 closed claims Obstet Gynecol 112 2008 1279 1283
15. Formweb. FDA black box warnings. < http://www.blackboxrx.com/app/ display.php?id=277 />; 2003 [accessed 5.10.10].
16. Institute for Safe Medical Practices. High alert medications. < http://www.ismp.org />; 2010(accessed 1.11.10.
17. E.J. Hayes, and L. Weinstein Improving patient safety and uniformity of care by a standardized regimen for the use of oxytocin Am J Obstet Gynecol 198 2008 622.e1 622.e7
18. S.L. Clark, K.R. Simpson, G.E. Knox, and T.J. Garite Oxytocin: new perspectives on an old drug Am J Obstet Gynecol 200 2009 35.e1 35.e6
19. L.A. Miller Oxytocin, excessive uterine activity, and patient safety: time for a collaborative approach J Perinat Neonatal Nurs 23 2009 52 58
20. M.C. Sarna, A.K. Soni, M. Gomez, and N.E. Oriol Intravenous oxytocin in patients undergoing elective cesarean section Anesth Analg 84 1997 753 756
21. M.B. Munn, J. Owen, R. Vincent, M. Wakefield, D.H. Chestnut, and J.C. Hauth Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial Obstet Gynecol 98 2001 386 390
22. J.C. Carvalho, M. Balki, J. Kingdom, and R. Windrim Oxytocin requirements at elective cesarean delivery: a dose-finding study Obstet Gynecol 104 2004 1005 1010
23. M. Balki, M. Ronayne, and S. Davies Minimum oxytocin dose requirement after cesarean delivery for labor arrest Obstet Gynecol 107 2006 45 50
24. C. Robinson, R. Schumann, P. Zhang, and R.C. Young Oxytocin-induced desensitization of the oxytocin receptor Am J Obstet Gynecol 188 2003 497 502
25. S. Phaneuf, G. Asboth, and M.P. Carrasco Desensitization of oxytocin receptors in human myometrium Hum Reprod Update 4 1998 625 633
26. J.K. Magalhaes, J.C. Carvalho, R.K. Parkes, J. Kingdom, Y. Li, and M. Balki Oxytocin pretreatment decreases oxytocin-induced myometrial contractions in pregnant rats in a concentration-dependent but not time-dependent manner Reprod Sci 16 2009 501 508
27. M. Balki, A.L. Cristian, J. Kingdom, and J.C. Carvalho Oxytocin pretreatment of pregnant rat myometrium reduces the efficacy of oxytocin but not of ergonovine maleate or prostaglandin F 2 alpha Reprod Sci 17 2010 269 277
28. R.S. Gibbs, B.Y. Karlan, A.F. Haney, and I.E. Nygaard Danforth's Obstetrics and Gynecology 10th ed. 2008 Lippincott, Williams & Wilkins Philadelphia
29. F. Cunningham, K. Leveno, S. Bloom, J. Hauth, D. Rouse, and C. Spong William's Obstetrics 23rd ed. 2009 McGraw Hill Medical New York
30. S.G. Gabbe, J.L. Simpson, and J.R. Niebyl Obstetrics fifth ed. 2007 Churchill Livingstone Philadelphia